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INTRODUCTION
The contributions of malaria to disease and socio-
economic burdens of the world are well documented1. In
spite of the currently increasing attention given to and
resources aimed at malaria control, including initiatives
such as Roll Back Malaria, the multilateral initiative on
malaria and the introduction of artemisinin-based com-
bination therapy, it remains a threat to the life of children
in sub-Saharan Africa1–2. Plasmodium falciparum infec-
tion is the major cause of morbidity and mortality among
children in Nigeria where malaria constitutes 25–40%
of all outpatient clinic visits and 21% of hospital admis-
sions3. It is one of the five leading causes of mortality in
children under-5 years of age4.
Glucose-6-phosphate dehydrogenase (G6PD)
deficiency on the other hand is the most common
enzymopathy of humans5. G6PD status is considered to
be one of the major determinants of host resistance to
childhood malaria infection6–8. It is a known cause of
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ABSTRACT
Background & objectives: Malaria and G6PD deficiency-related haemolyses are known causes of hospital
admissions in Nigeria and pose great danger to child survival but data on interactions of these two pathologies are
scarce. This study was carried out to determine the association between features of Plasmodium falciparum infection
and G6PD status.
Methods: G6PD and haemoglobin were typed by fluorescent spot test and electrophoresis respectively, in 1120
children with microscopically-proven falciparum malaria. Clinical features of malaria were compared between
G6PD normal and deficient children.
Results: There were 558 males and 562 females with median age of 35 months (range, 6 months–12 yr). In males,
prevalence of G6PD-deficiency in patients with uncomplicated malaria (UM), severe malarial anaemia (SMA)
and cerebral malaria (CM) was 23.4, 7 and 16.7%, respectively compared with 11.1, 7.3 and 4.4%, respectively
among females. In both males and females, convulsion and rectal temperature above 38°C were less likely
presentations among G6PD-deficient compared with G6PD-normal children (p <0.05). The proportions of children
with pallor, convulsion and impaired consciousness were significantly lower among G6PD-deficient than normal
males (p <0.05) but these features were not different between deficient and normal females (p >0.05).
Interpretation & conclusion: Convulsions, pallor and elevated temperature were more frequent features of malaria
in G6PD normal than deficient children. G6PD-deficient male children are protected against impaired consciousness.
These differences may offer useful hints in malaria treatment and researches in endemic regions.
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haemolysis and suspected to significantly alter endemic-
ity of malaria in the tropics9. The similarity of the geo-
graphical distribution of G6PD-deficiency and falciparum
malaria was pointed out by Allison10 and Motulsky11 in
1960. Since then many authors have reviewed the hy-
pothesis that G6PD-deficiency confers resistance to
falciparum malaria12–15. A recent study in Nigeria showed
that the prevalence of G6PD-deficiency among male
(16.4%) and female (8.1%) malaria patients were lower
than the general population16. The study also revealed
that G6PD-deficient male but not female children
were significantly less likely to develop severe malarial
anaemia16.
In situations where malaria eradication is not an op-
tion in the near future in Nigeria, emphasis must be given
on the control of morbidity and mortality due to malaria.
Under such circumstances making a distinction between
malarial parasitisation and malarial disease as well as rec-
ognizing factors that may contribute to malaria severity
are important. However, there is paucity of data on J Vector Borne Dis 51, March 2014 34
whether or not there are differences in the manifestations
of malaria between individuals with either homozygous
or heterozygous G6PD-deficiency and those with normal
G6PD activity. The knowledge of any peculiarity in the
manifestation of falciparum malaria in children with re-
spect to their G6PD status may be useful to shed more
light on the importance of checking G6PD status in chil-
dren who are known to be at higher risk of severe malaria
than adults. It may also help to identify the potential ar-
eas of priority in research. Therefore, this study was car-
ried out to describe the differences in the manifestations
of falciparum malaria among G6PD-deficient and G6PD-
normal children in Ibadan, in order to provide data that
may help to improve the management and reduce mor-
bidity and mortality due to malaria.
MATERIAL & METHODS
Study design and setting
Consecutive patients with symptomatic P. falciparum
malaria were screened for G6PD-deficiency over a study
period of 24 months (April 2005 to March 2007) at the
outpatient and emergency unit of the University College
Hospital, Ibadan, Nigeria. The hospital is located in Ibadan
North Local Government Area. Ibadan is an urban city in
the southwest of Nigeria, an area of malaria hyperende-
micity. Ibadan has an estimated population of 2,550,393
and annual growth rate of 2.83% (2006 census). Majority
of the inhabitants of Ibadan are mainly Yoruba speaking
people. All the children with severe malaria were first
admitted into the emergency ward which has side labora-
tory where simple ancillary investigations including mi-
croscopy and haematocrit are carried out.
Inclusion and exclusion criteria
Children who presented with fever had peripheral
blood film examination for P. falciparum17. Those
who had malaria parasitaemia were recruited provided
there was no other obvious cause for the fever such as
respiratory infections. Patients who were later found
to have sickle-cell anaemia with haemoglobin genotype
“SS” or “SC”and those who had blood transfusion
within three months before enrolment were excluded from
the study.
Data collection
History was obtained from the care givers and the
children. Complete physical examination was carried out
on each patient. All the findings including the results of
G6PD test, packed cell volume (PCV), parasite counts,
blood groups and haemoglobin types were recorded by
the investigators into a case record form. Cases of severe
malaria were defined according to WHO criteria18.
Laboratory procedures
Thick and thin films were made on the same slide for
each patient. The thin film was fixed with methanol imme-
diately and the slide was allowed to dry, then flooded with
Giemsa stain already diluted (1 in 10) with phosphate buffer
(pH 6.8). The stain was washed off with distilled water,
after allowing it to stay for about 10 min, and air-dried.
The stained films were then examined microscopically for
malaria parasites. The parasites were counted against 200
white blood cells (WBC) and parasite density was calcu-
lated for each patient based on total WBC of 8000/μl of
blood. Haematocrit, haemoglobin types and ABO blood
groups were determined using capillary tube plus centrifu-
gation, electrophoresis on cellulose acetate and agglutina-
tion tile19 methods respectively. G6PD status was deter-
mined by fluorescent spot test according to the method of
Beutler and Mitchell20. This test is based on the principle
that NADPH generated in red cells in the presence of G6PD,
fluoresces under long wavelength ultraviolet (UV) light.
The drawback of this method is that it does not distinguish
between heterozygote and homozygote G6PD normal fe-
males.
Quality controls
There was no attempt to distinguish clinical features
between G6PD normal and deficient children until screen-
ing was done in order to minimize selection bias. A par-
allel G6PD screening test of some of the patients in each
batch was carried out in the Paediatric Research Labora-
tory. This laboratory has been running G6PD screening
for over 15 yr. All children with severe anaemia (PCV
< 15%) had repeat G6PD screening three months after
blood transfusion. There was over 98% agreement rate
in the results obtained (Kappa = 0.9874).
Data analysis
Data were analyzed using SPSS 15.0 for Windows
(SPSS Inc., Chicago, USA).  Stratified analysis of the
various manifestations of malaria infection by gender was
carried out in order to control for its confounding effect.
Categorical variables were compared using either the
uncorrected chi-square test or Fisher’s exact test while
continuous variables were analyzed using the Student t-
test or analysis of variance (ANOVA). Data not normally
distributed were compared using Mann-Whitney U-test.
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Ethical consideration
Written informed consent was obtained from the care-
givers and the protocol was approved by the University
of Ibadan/University College Hospital Ethical Review
Committee (IRC Protocol No.: UI/IRC/O4/0001).
RESULTS
The age of the patients who participated in this study
ranged from 6 months to 12 yr with a mean of 41.4 ± 1.2
months. The mean age of the G6PD-deficient group of
45.2 months was not significantly different from 37.8
months in the G6PD-normal (p = 0.060). Infants (6 to 11
months) constituted 11.8% of all the study patients. Chil-
dren who were 12 to 23, 24 to 35, 36 to 47 and 48 to 59
months old were 23.1, 15.3, 13.7 and 13.4%, respectively.
Thus, under-5 children constituted 77.3% of all the study
patients while those >5 yr were 27.7%. Study patients
were 451 (251 males) uncomplicated malaria (UM), 428
(252 males) severe malarial anaemia and 241 (155 males)
cerebral malaria. Prevalence of G6PD-deficiency in
patients with UM, SMA, and CM was 18.1, 7.2 and 9.3%,
respectively. The prevalence of G6PD-deficiency in male
patients with UM, SMA and CM was 23.4, 7 and 16.7%,
respectively. However, in the females category, preva-
lence of G6PD-deficiency among patients with UM, SMA
and CM was 11.1, 7.3 and 4.4%, respectively. Of the 1120
study patients, there were 19 deaths giving an overall
mortality rate of 1.7%. Other demographic characteris-
tics of the study patients are shown in Table 1. Overall,
the prevalence of G6PD-deficiency was significantly
higher among males (16.7%) than females (8.3%); p
<0.001.  The patients’ weight ranged from 5.5 to 32 kg
with an overall mean weight of 13.4 ± 5.3 kg. The G6PD-
deficient and G6PD-normal patients had a mean weight
of 14.3 ± 5.6 and 12.9 ± 4.9 kg, respectively (p = 0.057).
All the 1120 patients had Hb type A. The proportion
of G6PD-deficient patients with blood group O, A, B and
AB was 57.1, 23.4, 15.6 and 3.9%, respectively. This pat-
tern of distribution did not significantly differ from 58.7,
19.2, 18.9 and 3.1% for blood group O, A, B and AB,
respectively among the G6PD-normal group (p = 0.681).
The haematocrit of all the patients ranged from 6 to 45%
and the mean PCV was 21%. The mean haematocrit of
the G6PD-normal (22.8%) was not significantly differ-
ent from G6PD-deficient children (21%); p = 0.092. The
mean parasite counts of 15,477.5/μl (range = 5340 to
860,000) in G6PD-deficient patients was significantly
lower than (19,784.4/μl, range = 2112 to 1824,400) in
the G6PD-normal group (p = 0.013). However, in the male
children, the mean parasite count was 15397/μl (range =
4240 to 880,000) in G6PD-deficient patients. This esti-
mate was significantly lower than (24,662.8/μl; range =
3140 –1,824,400) in the G6PD-normal group (p = 0.041).
Conversely, in the females category, though the G6PD-
deficient group had a lower mean parasite counts
(12,840.4/μl; range = 2960–860,000), but it was not signi-
ficantly different from (15,548.6/μl; range=2102–969,882)
estimated for the G6PD-normal group (p = 0.419).
The comparisons of the clinical features of malaria
in G6PD-deficient and normal male patients are shown
in Table 2. In the male category, more of those with nor-
mal G6PD status than G6PD-deficient presented with
pallor (68.8% vs 45.2%), convulsions (30.3% vs 14%),
impaired consciousness (30.8% vs 16.1%) and tempera-
ture above 37.5°C (77.4% vs 99.8%). On the others hand,
more of those with G6PD-deficiency than G6PD-normal
patients passed dark urine (35.5% vs 18.1%) and had pal-
Table 1. Comparison of gender, age and weight of 1120 malaria patients based on G6PD status
Characteristics G6PD status Total (n = 1120) p = value
Deficient (n = 139) Normal (n = 981)
Gender
Male 93 (66.9) 465 (47.4) 558 (49.8) <0.001*
Female 46 (33.1) 516 (55.7) 562 (50.2)
Age (Months)
Range 6–144 6–138 6–144 0.060**
Mean 45.2 37.8 41.4
SD 1.8 1.6 1.2
Weight (kg)
Range 5.5–32 5.7–32 5.5–32 0.022+
Mean 14.3 12.9 13.4
SD 5.6 4.9 5.3
*Chi-square test; **Student t-test; +Mann-Whitney U-test (M-W U); SD = Standard deviation; Values in parentheses are percentages. J Vector Borne Dis 51, March 2014 36
pable spleen (66.7% vs 51.2%). However, there was no
significant difference in the proportions of G6PD-defi-
cient and normal patients who presented with fever, vom-
iting, cough, diar-rhoea, difficulty in breathing, jaundice,
liver enlargement (>2 cm below the right costal margin)
and respiratory distress.
Table 3 shows the comparisons of the clinical fea-
tures of malaria in G6PD-deficient and normal female
patients. The proportions of patients who presented with
dark urine (8.7%), convulsions (8.7%) and temperature
>38°C (54.7%) in G6PD-deficient group were signifi-
cantly lower than 34.7, 22.7 and 98.6%, respectively in
the G6PD-normal group. There was no statistically sig-
nificant difference in the proportions of patients who pre-
sented with pallor, fever, vomiting, cough, diarrhoea, dif-
ficulty in breathing, palpable spleen, jaundice, liver size
>2 cm and respiratory distress in the G6PD-normal and
deficient groups.
All the deaths were due to cerebral malaria, with a
case fatality rate of 7.9% (19/241). Whereas, no death
occurred among the G6PD-deficient patients in this study,
all the dead patients were G6PD-normal.  Visual and hear-
ing impairment was documented at the time of discharge
in four patients with cerebral malaria.
Table 3. Clinical features of malaria among glucose-6-phosphate dehydrogenase normal and deficient female patients
Clinical features G6PD status OR 95% CI p-value*
Deficient (n = 46) Normal (n = 516)
No. % No. %
Pallor 10 21.8 109 21.1 1.04 0.50–2.16 0.927
Dark urine 4 8.7 179 34.7 0.18 0.06–0.51 <0.001
Convulsion 4 8.7 114 22.1 0.39 0.21–0.73 <0.001
Impaired consciousness 8 17.4 91 17.6 0.98 0.44–2.18 0.872
Fever 45 97.8 516 100 0 0–1.69 0.163
Vomiting 7 15.2 125 24.2 0.56 0.24–1.29 0.230
Cough 5 10.9 48 9.3 1.19 0.45–3.15 0.932
Diarrhoea 32 69.6 356 69 1.03 0.53–1.98 0.931
Difficulty in breathing 2 4.3 32 6.2 0.69 0.16–2.96 0.855
Temperature (>38ºC) 35 54.7 509 98.6 0.02 0.01–0.04 <0.001
Palpable spleen 25 39.1 147 28.5 1.61 0.94–2.75 0.109
Jaundice 4 8.7 11 2.1 3.06 0.94–9.91 0.072
Liver size (>2 cm) 4 8.7 77 14.9 0.38 0.13–1.08 0.825
Respiratory distress 28 43.8 170 32.9 1.58 0.93–2.68 0.094
*Chi-square test used; OR – Obtained from 2 × 2 table for each clinical feature.
Table 2. Clinical features of malaria among glucose-6-phosphate dehydrogenase normal and deficient male patients
Presenting complaints G6PD status OR 95% CI p-value*
Deficient (n = 93) Normal (n = 465)
No. % No. %
Pallor 42 45.2 320 68.8 0.37 0.24–0.59 <0.001
Dark urine 33 35.5 84 18.1 2.49 1.53–4.06 <0.001
Convulsion 13 14 141 30.3 0.37 0.20–0.69 0.002
Impaired consciousness 15 16.1 143 30.8 0.43 0.24–0.78 0.006
Fever 91 97.8 463 99.6 0.20 0.03–1.41 0.262
Vomiting 44 47.3 185 39.8 1.20 0.55–2.62 0.801
Cough 4 4.3 27 5.8 0.73 0.25–2.14 0.741
Diarrhoea 4 4.3 22 4.7 0.91 0.30–2.69 0.928
Difficulty in breathing 11 11.8 53 11.4 1.04 0.52–2.08 0.952
Temperature (>37.5ºC) 72 77.4 464 99.8 0.12 0.01–0.06 <0.001
Palpable spleen 62 66.7 238 51.2 1.90 1.19–3.05 0.006
Jaundice 6 6.5 18 3.9 1.67 0.68–4.09 0.264
Liver enlargement (>2 cm) 67 72 286 61.5 1.61 0.99–2.63 0.055
Respiratory distress 18 19.4 92 19.8 0.97 0.55–1.71 0.924
*Chi-square test used; OR – Obtained from 2 × 2 table for each clinical feature. 37 Orimadegun & Sodeinde : Features and outcomes of malaria infection
DISCUSSION
This study has shown that convulsions and elevated
body temperature were more frequent features of malaria
in G6PD-normal than deficient children in both males
and females. The G6PD-deficient male, not female chil-
dren showed protection against pallor and impaired con-
sciousness as clinical signs during malarial illness. How-
ever, G6PD-deficient males were more likely to present
with dark urine and enlarged spleen than G6PD-normal
ones. These differences were not influenced by blood
group and haemoglobin types. Also, there was male pre-
ponderance in all three types of malaria in this study and
majority of affected children were <5 yr. The relative
dominance of male children in the study population re-
flects the pattern of male to female ratio of malarial
infection and admissions into the typical Nigeria tertiary
hospitals that have been previously reported4, 16, 21–22. Glo-
bally, malaria affects more under-5 than older children in
endemic regions mainly because of adaptive immunity
against malaria which results from repeated malaria at-
tacks is often not sufficiently strengthened until  five
years18.
Fever was the most common presenting complaint
among the study patients. This agrees with previous stud-
ies which showed that fever was the most common rea-
son for which caregivers sought healthcare for children
with malaria in endemic countries, particularly in Nige-
ria21, 23. However, fever could sometimes be under re-
ported or exaggerated as in a recent study which showed
that the sensitivity of tactile assessment for fever could
be a as low as 23% among caregivers in emergency
setting24. On the other hand, fever has been a useful
index in monitoring recovery during treatment of ma-
laria among children. In an earlier study of  inpatients
suffering from falciparum malaria, individuals with nor-
mal G6PD status had almost double the fever clearance
time compared to those with G6PD-deficiency, an
indication of a protective role conferred by low G6PD
levels25.
The present study showed no significant association
between jaundice and G6PD status in both male and fe-
male malaria patients. This implies that jaundice may not
be a good distinguishing feature of malaria between
G6PD-normal and deficient children. There is a wide
variation in the reports of jaundice in malaria among chil-
dren. Massive intravascular haemolysis of parasitized red
blood cells, malarial hepatitis, antimalarial drug induced
haemolysis, coexisting acute viral hepatitis and underly-
ing chronic hepatitis, are recognized mechanisms of jaun-
dice in falciparum malaria26. While, G6PD-defi-
ciency may confer protection against malaria, it may
also be the cause of haemolysis and jaundice among
the malaria patients. In a study of 35 children with
G6PD-deficiency who presented with acute intravascu-
lar haemolysis, malaria was the incriminating factor
responsible for haemolysis in four children9. Antimalarial
drugs such as quinine and primaquine may also
precipitate haemolysis in G6PD-deficient individuals18.
However, the number of children who received these
drugs before admission to the study centre was not docu-
mented in the present study since the drugs were
only recommended for use in the hospital settings in
Nigeria27.
Liver enlargement (>2 cm below the right costal mar-
gin) was not associated with G6PD status among malaria
patients in this study. The implication of this finding is
that liver enlargement can not be a good discriminatory
clinical feature of malaria between G6PD-normal and de-
ficient children. Though, no previous study had elucidated
the difference in presence of enlarged liver between
G6PD-normal and deficient patients during malaria ill-
ness. A study28 in the same hospital earlier showed that
Nigerian children with acute falciparum malaria had com-
plete resolution of hepatomegaly in 41% of children after
recovery from the acute illness (by Days 7 or 14), and
persistent hepatomegaly was common among children
who failed to clear parasitaemia by Day 7 after appro-
priate treatments28.
The proportions of G6PD-deficient children who pre-
sented with convulsions in male and female categories
were lower than 69.6% that was earlier reported by
Hendrickse et al29, among malaria patients. Contrary to
the findings of protection against occurrence of convul-
sions in the present study, Hendrickse et al29 reported that
convulsions were more frequent among G6PD-deficient
patients than normal children. However, it is important
to note that the present study included both children
treated on outpatient and admission. Children studied by
Hendrickse et al29 were those admitted and were likely to
be selectively biased, this may explain the high frequency
of convulsions among the subjects. The present study,
therefore, suggests that the cerebral involvement is less
likely in G6PD-deficient children compared with normal
children.
Our data also revealed no relationship between oc-
currence of respiratory distress and G6PD-deficiency in
both male and female malaria patients. Respiratory dis-
tress being a summary description applied to children who
have obviously abnormal breathing pattern involving the J Vector Borne Dis 51, March 2014 38
use of more effort than usual could be an important risk
factor for death among children with malaria30. Similarly,
respiratory distress has been shown to adversely affect
the outcome of childhood cerebral malaria among Nige-
rian children22. However, it is not clear from our data
why a significantly less proportion of G6PD-deficient
patients would have respiratory distress compared with
normal children. The study did not investigate other
possible causes of respiratory distress, such as acidosis,
pneumonia and deep sequestration of parasites in the
pulmonary vascular bed. None of the patients in the
series had abnormal breath sounds.
In Nigeria, presumptive treatments of malaria based
on the use of clinical signs and symptoms are recom-
mended in settings where microscopy is not feasible and
could cause  delay in commencing antimalarial drugs27.
Given this background, distinguishing between children
who are likely to be G6PD-normal or deficient would be
of value in a making safer choice of antimalarial. There
is a  drawback of the G6PD-deficiency screening test
(fluorescent spot) used in this study. Fluorescent spot-
test does not distinguish between heterozygote and ho-
mozygote G6PD-normal individuals and this limits the
generalisability of the data to these categories of children.
Nonetheless, this study suggests that malaria manifests
different recognizable features in G6PD-normal and de-
ficient children. Convulsion and elevated body tempera-
ture occurred more frequently in G6PD-normal than de-
ficient in both males and females while pallor, impaired
consciousness and enlarged spleen were more common
features of malaria in G6PD-normal than deficient male
but not female children. These differences may offer use-
ful hints in the choice of antimalarial treatments and re-
searches in endemic regions.
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